I-SPY 2 Trial segment on NBC Nightly News
The I-SPY2 Trial was featured in an NBC Nightly News segment on Monday, December 19th. The introduction by Brian Williams states “Right now, as you may know, it typically takes a decade or more to...
View ArticleJAMA publishes Commentary about accelerating approval of new cancer treatments
The December 21, 2011 issue of the Journal of the American Medical Association includes a Commentary entitled “Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs”...
View ArticleFDA release draft Guidance for accelerated approval of breast cancer...
A New Clinical Trial Design Promises to Accelerate Cancer Drug Approvals BETHESDA, MD (June 1, 2012) – The Food and Drug Administration (FDA) has drafted a regulatory guidance describing a new way of...
View ArticleI-SPY 2 Trial cited in President’s Council of Advisors on Science and...
A report from the President’s Council of Advisors on Science and Technology, released on September 25, 2012, cites an urgent need to reform the process of researching, testing and approving new drug...
View ArticleI-SPY 2 featured in Innovators Presentation by FasterCures 2013
FasterCures, the Washington, DC-based center of the Milken Institute, convened the fifth annual Partnering for Cures meeting Nov. 3-5 in New York. Partnering for Cures brings together leaders from all...
View ArticleI-SPY 2 Announces Successful Graduation of 2 New Breast Cancer Treatments
December 13, 2013 – Wall Street Journal article by Ron Winslow: http://online.wsj.com/news/articles/SB10001424052702303293604579255831485652454?KEYWORDS=i-spy Two Experimental Breast-Cancer Drugs...
View ArticleCureus Authors in the News: Dr. Laura Esserman’s I-SPY TRIAL
Transcribed from the Cureous Blog: http://blog.cureus.com/2014/01/10/cureus-authors-in-the-news-dr-laura-essermans-i-spy-trial/ Dr. Laura Esserman, the principal investigator for the I-SPY adaptive...
View Article
